Supha Pharmachem Ltd share price
You have to be logged in to add this to Watchlist.- ₹0.44(4.76%)April 17, 2026 15:58:32 PM IST
- NSE
- BSE
- Vol : 3.42 M (NSE + BSE)Last 20 day avg : 8.58 M
Supha Pharmachem Ltd is trading 4.76% upper at Rs 0.44 as compared to its last closing price. Supha Pharmachem Ltd has been trading in the price range of 0.44 & 0.42. Supha Pharmachem Ltd has given -44.00% in this year & 16.67% in the last 5 days. Supha Pharmachem Ltd has TTM P/E ratio 11.83 as compared to the sector P/E of 24.14.The company posted a net profit of 8.62 Crores in its last quarter.Listed peers of Supha Pharmachem Ltd include Sun Pharmaceutical Industries (-1.06%), Torrent Pharmaceuticals (0.78%), Divi's Laboratories (-1.06%).The Mutual Fund holding in Supha Pharmachem Ltd was at -% in . The MF holding has - from the last quarter. The FII holding in Supha Pharmachem Ltd was at 1.70% in 31 Dec 2025. The FII holding has increased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Apr 19, 2026, 10:52 AM UTC
- BetaHigh volatility1.93Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry26.01The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- P/BLower than historical values0.55The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/ELower than historical values3.38Price-to-earnings ratio based on trailing 12-month earnings
- PEG RatioIndicates undervaluation0.13The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | Bearish | 1,675.20 | -1.06 | 4,01,927.13 | 33.67 | 5.36 | 0.99 | 0.50 |
| Torrent Pharmaceuticals | Bullish | 4,188.95 | 0.78 | 1,41,699.22 | 69.82 | 17.73 | 0.80 | 17.62 |
| Divi's Laboratories | Neutral | 6,230.60 | -1.06 | 1,65,415.99 | 72.76 | 10.66 | 0.50 | 0.01 |
| Cipla | Neutral | 1,238.30 | 0.61 | 1,00,027.73 | 21.14 | 3.57 | 0.94 | 0.81 |
| Lupin | Bullish | 2,321.40 | -0.22 | 1,06,303.19 | 29.62 | 5.75 | 0.55 | 11.80 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-03-30 | Quarterly Results |
| 2026-03-09 | Quarterly Results |
| 2026-02-25 | Quarterly Results |
| 2026-02-14 | Quarterly Results |
| 2025-11-14 | Quarterly Results |
- IndustryBiotechnology & Drugs
- ISININE549S01036
- BSE Code539561
- NSE Code
Supha Pharmachem Ltd is trading at 0.44 as on Fri Apr 17 2026 10:28:32. This is 4.76% upper as compared to its previous closing price of 0.42.
The market capitalization of Supha Pharmachem Ltd is 38.80 Cr as on Fri Apr 17 2026 10:28:32.
The 52 wk high for Supha Pharmachem Ltd is 1.94 whereas the 52 wk low is 0.32
Supha Pharmachem Ltd can be analyzed on the following key metrics -
- TTM P/E: 11.83
- Sector P/E: 24.14
- Dividend Yield: 0.00%
- D/E ratio: 10.34
Supha Pharmachem Ltd reported a net profit of 2.13 Cr in 2025.
EQUITY QUICK LINKS
Supha Pharmachem Ltd QUICK LINKS
FROM MARKETS
RELATED LINKS
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.